Personalis, Inc. (PSNL)
| Previous close | 1.5650 |
| Open | 1.7100 |
| Bid | 1.6200 x 400 |
| Ask | 1.6700 x 200 |
| Day's range | 1.5900 - 1.7501 |
| 52-week range | 0.8910 - 2.6000 |
| Volume | |
| Avg. volume | 317,260 |
| Market cap | 84.496M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Personalis Reports First Quarter 2024 Financial Results
FREMONT, Calif., May 08, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the first quarter of 2024 ended March 31, 2024, and provided recent business highlights.
- Business Wire
Personalis to Announce First Quarter 2024 Financial Results
FREMONT, Calif., April 24, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its first quarter 2024 financial results on Wednesday, May 8, 2024. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.
- Business Wire
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
FREMONT, Calif., March 28, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time.
